BG63460B1 - D-манитол и метод за неговото получаване - Google Patents

D-манитол и метод за неговото получаване Download PDF

Info

Publication number
BG63460B1
BG63460B1 BG102818A BG10281898A BG63460B1 BG 63460 B1 BG63460 B1 BG 63460B1 BG 102818 A BG102818 A BG 102818A BG 10281898 A BG10281898 A BG 10281898A BG 63460 B1 BG63460 B1 BG 63460B1
Authority
BG
Bulgaria
Prior art keywords
mannitol
crystals
examples
hydrochloride
tablet
Prior art date
Application number
BG102818A
Other languages
Bulgarian (bg)
English (en)
Other versions
BG102818A (en
Inventor
Tomohiro Yoshinari
Fritz Schueckler
Norbert Poellinger
Shinji Maegata
Original Assignee
Bayer Aktiengesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=14109240&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=BG63460(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bayer Aktiengesellschaft filed Critical Bayer Aktiengesellschaft
Publication of BG102818A publication Critical patent/BG102818A/xx
Publication of BG63460B1 publication Critical patent/BG63460B1/bg

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C31/00—Saturated compounds having hydroxy or O-metal groups bound to acyclic carbon atoms
    • C07C31/18—Polyhydroxylic acyclic alcohols
    • C07C31/26—Hexahydroxylic alcohols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C29/00—Preparation of compounds having hydroxy or O-metal groups bound to a carbon atom not belonging to a six-membered aromatic ring
    • C07C29/74—Separation; Purification; Use of additives, e.g. for stabilisation
    • C07C29/76—Separation; Purification; Use of additives, e.g. for stabilisation by physical treatment
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Chemical Or Physical Treatment Of Fibers (AREA)
  • Steroid Compounds (AREA)
  • Developing Agents For Electrophotography (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
BG102818A 1996-04-16 1998-10-07 D-манитол и метод за неговото получаване BG63460B1 (bg)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9440196 1996-04-16
PCT/JP1997/001286 WO1997038960A1 (en) 1996-04-16 1997-04-14 D-mannitol and its preparation

Publications (2)

Publication Number Publication Date
BG102818A BG102818A (en) 1999-05-31
BG63460B1 true BG63460B1 (bg) 2002-02-28

Family

ID=14109240

Family Applications (1)

Application Number Title Priority Date Filing Date
BG102818A BG63460B1 (bg) 1996-04-16 1998-10-07 D-манитол и метод за неговото получаване

Country Status (27)

Country Link
US (1) US6503918B2 (pt)
EP (1) EP0902777B2 (pt)
KR (1) KR20000005486A (pt)
CN (1) CN1221398A (pt)
AT (1) ATE202768T1 (pt)
AU (1) AU718658B2 (pt)
BG (1) BG63460B1 (pt)
BR (1) BR9708672A (pt)
CA (1) CA2251092A1 (pt)
CU (1) CU22776A3 (pt)
CZ (1) CZ333698A3 (pt)
DE (1) DE69705516T3 (pt)
DK (1) DK0902777T4 (pt)
EA (1) EA000968B1 (pt)
ES (1) ES2158540T5 (pt)
GR (1) GR3036760T3 (pt)
HU (1) HUP9902165A3 (pt)
ID (1) ID16566A (pt)
IL (1) IL126580A (pt)
NO (2) NO311349B1 (pt)
NZ (1) NZ332313A (pt)
PL (1) PL329614A1 (pt)
PT (1) PT902777E (pt)
SK (1) SK282768B6 (pt)
TR (1) TR199802079T2 (pt)
TW (1) TW515787B (pt)
WO (1) WO1997038960A1 (pt)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10008506A1 (de) * 2000-02-24 2001-09-13 Bayer Ag Verfahren zur Herstellung von pharmazeutischen Darreichungsformen
FR2807034B1 (fr) † 2000-03-29 2002-06-14 Roquette Freres Mannitol pulverulent et son procede de fabrication
AU2001290239A1 (en) * 2000-09-19 2002-04-02 Daiichi Pharmaceutical Co., Ltd. Medicinal composition
US6979462B1 (en) 2000-10-03 2005-12-27 Mutual Pharmaceutical Co., Inc. Stabilization of solid drug formulations
US6855333B1 (en) 2000-10-03 2005-02-15 Mutual Pharmaceutical Co., Inc. Stabilization of solid thyroid drug formulations
DE10161402A1 (de) * 2001-12-13 2003-06-18 Merck Patent Gmbh Verfahren zur Herstellung von direkt tablettierbarem beta-Mannit
JP4808960B2 (ja) * 2002-05-14 2011-11-02 エフ エム シー コーポレーション 微結晶質セルロース組成物
US8163797B2 (en) * 2003-12-31 2012-04-24 Actavis Elizabeth Llc Method of treating with stable pravastatin formulation
US7879382B2 (en) * 2005-09-30 2011-02-01 Fmc Corporation Stabilizers and compositions and products comprising same
US8486450B2 (en) 2005-12-28 2013-07-16 Takeda Pharmaceutical Company Limited Method of producing solid preparation disintegrating in the oral cavity
AU2007218733B2 (en) 2006-02-20 2012-11-15 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition comprising oseltamivir phosphate
WO2008057266A2 (en) * 2006-10-27 2008-05-15 Fmc Corporation Dry granulation binders, products, and use thereof
BRPI0808889A2 (pt) * 2007-03-13 2014-11-11 Dainippon Sumitomo Pharma Co Comprimido desintegrante oral
US8389778B2 (en) * 2007-05-22 2013-03-05 Aptuit (West Lafayette), Llc Preparation of mannitol modification III
DE102007052070A1 (de) 2007-10-30 2009-05-07 Tiefenbacher Pharmachemikalien Alfred E. Tiefenbacher Gmbh & Co. Kg Candesartancilexetil
PL3093011T3 (pl) 2010-12-17 2021-09-06 Merck Patent Gmbh Sposób otrzymywania bezpośrednio tabletkowalnego delta-mannitolu
BR112014007366B1 (pt) 2011-10-05 2020-09-15 Dupont Nutrition Usa, Inc Processo para fabricar uma composição estabilizadora compreendendo extrusão em duas etapas, composição estabilizadora de celulose microcristalina e produto alimentício comestível e suspensão industrial compreendendo a mesma
ES2657648T3 (es) 2011-10-05 2018-03-06 Fmc Corporation Composición estabilizadora de celulosa microcristalina y carboximetilcelulosa co-reducida, método para elaborarla y usos
EP2787837B1 (en) 2011-12-09 2017-03-15 FMC Corporation Co-attrited stabilizer composition
JP6803325B2 (ja) * 2014-07-21 2020-12-23 ロケット フレールＲｏｑｕｅｔｔｅ Ｆｒｅｒｅｓ アルロースの製造方法及び錠剤の製造方法
IT201900002857A1 (it) 2019-02-27 2020-08-27 Ntc S R L Procedimento di riempimento di contenitori con una polvere
EP4129342B1 (en) * 2020-03-31 2025-10-15 Eisai R&D Management Co., Ltd. Tablet, medicine, and method and kit for manufacturing said tablet and medicine
CN113116843A (zh) * 2021-05-11 2021-07-16 福建海西新药创制有限公司 一种含有缬沙坦的药物组合物及其制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3145146A (en) 1961-10-31 1964-08-18 Warner Lambert Pharmaceutical Modified mannitol for pharmaceutical tablets
DE3245170A1 (de) 1982-12-07 1984-06-07 Merck Patent Gmbh, 6100 Darmstadt Verbesserter sorbit, verfahren zur herstellung und verwendung
FR2571045B1 (fr) 1984-10-03 1987-12-11 Roquette Freres Mannitol granulaire directement compressible et son procede de fabrication
FR2571046B1 (fr) 1984-10-03 1987-10-16 Roquette Freres Procede de preparation de mannitol granulaire directement compressible
JPH0653658B2 (ja) 1984-12-17 1994-07-20 中外製薬株式会社 安定な錠剤の製造法
NO177005C (no) 1988-01-20 1995-07-05 Bayer Ag Analogifremgangsmåte for fremstilling av substituerte pyridiner, samt mellomprodukter til bruk ved fremstillingen
ATE128959T1 (de) 1989-01-24 1995-10-15 Spi Polyols Inc Kryoschützende kristalline sorbitolkügelchen.
EP0390435B1 (en) 1989-03-29 1994-01-05 Takeda Chemical Industries, Ltd. Vitamin B group compound composition and its production
US5177080A (en) 1990-12-14 1993-01-05 Bayer Aktiengesellschaft Substituted pyridyl-dihydroxy-heptenoic acid and its salts
HU9203780D0 (en) * 1991-12-12 1993-03-29 Sandoz Ag Stabilized pharmaceutical products of hmg-coa reductase inhibitor and method for producing them
FR2710637B1 (fr) 1993-09-28 1995-12-08 Roquette Freres Mannitol pulvérulent de friabilité modérée et son procédé de préparation.
AUPM411494A0 (en) 1994-02-25 1994-03-24 Central Sydney Area Health Service Method and device for the provocation of upper or lower airway narrowing and/or the induction of sputum
US6235947B1 (en) * 1997-04-14 2001-05-22 Takeda Chemical Industries, Ltd. D-mannitol and its preparation

Also Published As

Publication number Publication date
KR20000005486A (ko) 2000-01-25
IL126580A0 (en) 1999-08-17
CU22776A3 (es) 2002-07-24
HUP9902165A3 (en) 2001-01-29
GR3036760T3 (en) 2001-12-31
DE69705516T2 (de) 2002-04-25
WO1997038960A1 (en) 1997-10-23
DK0902777T3 (da) 2001-09-24
DK0902777T4 (da) 2004-10-11
TR199802079T2 (xx) 1999-02-22
NO984803D0 (no) 1998-10-15
EP0902777B2 (en) 2004-06-16
TW515787B (en) 2003-01-01
NZ332313A (en) 2000-02-28
DE69705516T3 (de) 2004-09-30
EP0902777A1 (en) 1999-03-24
AU718658B2 (en) 2000-04-20
NO984803L (no) 1998-12-16
US6503918B2 (en) 2003-01-07
BR9708672A (pt) 1999-08-03
ES2158540T3 (es) 2001-09-01
SK282768B6 (sk) 2002-12-03
ID16566A (id) 1997-10-16
CZ333698A3 (cs) 1999-01-13
BG102818A (en) 1999-05-31
EA000968B1 (ru) 2000-08-28
US20020107420A1 (en) 2002-08-08
CA2251092A1 (en) 1997-10-23
AU2522297A (en) 1997-11-07
EA199800888A1 (ru) 1999-04-29
CN1221398A (zh) 1999-06-30
NO20012249L (no) 1998-12-16
IL126580A (en) 2001-08-08
PT902777E (pt) 2001-11-30
NO311349B1 (no) 2001-11-19
PL329614A1 (en) 1999-03-29
ATE202768T1 (de) 2001-07-15
ES2158540T5 (es) 2004-11-16
HUP9902165A2 (hu) 1999-11-29
DE69705516D1 (de) 2001-08-09
NO20012249D0 (no) 2001-05-07
SK143298A3 (en) 1999-04-13
EP0902777B1 (en) 2001-07-04

Similar Documents

Publication Publication Date Title
BG63460B1 (bg) D-манитол и метод за неговото получаване
US6235947B1 (en) D-mannitol and its preparation
EP0580428B1 (en) Microparticle preparation and production thereof
EP0535937B2 (en) Prolonged release microparticle preparation and production of the same
DE69519685T2 (de) Oral anzuwendende arzneizubereitung mit verzögerter wirkstoffabgabe
JP3126683B2 (ja) Ｄ−マンニトールおよびその製造法
US20010001106A1 (en) D-mannitol and its preparation
US7018653B2 (en) Method for preparing solid dosage form of desmopressin
CN102247367B (zh) 一种含替米沙坦氨氯地平药物组合物及制备方法
DE60303872T2 (de) Verfahren zur Herstellung einer festen oralen Dosierungsform von Desmopressin
JP2001114712A (ja) Ｄ−マンニトールおよびその製造法
Singh et al. Liquisolid compacts of glimepiride: an approach to enhance the dissolution of poorly water soluble drugs
JPH1135487A (ja) 錠剤用組成物及び打錠方法
HK1020567A (en) D-mannitol and its preparation
JP3232687B2 (ja) イミダプリル含有製剤
HK40072809A (en) Tablet comprising atorvastatin and ezetimibe
EP2808012A1 (en) Method for producing dosage form comprising odanacatib
RU2006120954A (ru) Способ приготовления твердой лекарственной формы десмопрессина
HK1206245A1 (en) (z)-2-cyano-3-hydroxy-but-2-enoic acid-(4'-trifluormethylphenyl)-amide tablet formulations with improved stability